Bendheim Daniel M 4

What Happened

Daniel M. Bendheim, President, CEO and a director of Phibro Animal Health Corp (PAHC), was granted 300,000 performance stock units (PSUs) on 2026-07-01. The PSUs are derivative awards (transaction code A) reported as acquired at $0.00 and carry no immediate cash proceeds. These units represent contingent rights to receive Class A common shares if vesting conditions are met.

Key Details

• Transaction date: 2026-07-01; filing date: 2026-07-02 (timely Form 4).
• Grant: 300,000 PSUs; reported price: $0.00; classification: derivative award (A).
• Shares owned after transaction: Not disclosed in this filing.
• Footnote summary:
  • F1: Each PSU equals a contingent right to one share of Class A common stock.
  • F2: PSUs vest (in whole or in part) only on June 30, 2031, subject to specified stock-price performance measured as of that date and the reporting person’s continued employment (i.e., contingent on performance and service).
• No indication of a sale, purchase, or tax-withholding event in this filing.

Context

This is a compensatory equity award, not an open-market purchase or sale—awards like these are commonly part of executive pay packages and are contingent on future performance/service conditions. Because the PSUs only convert to shares if performance targets are met by 6/30/2031 and the CEO remains employed, there is no immediate transfer of shares or cash and no direct near-term market signal from this filing.